History of Acute Leukemia
4. Pearson OH, Eliel LP, Rawson RW, et al. ACTH- and cortisone-induced regression of lymphoid tumors in man. Cancer. 1949;2:943–5.PubMed
4. Pearson OH, Eliel LP, Rawson RW, et al. ACTH- and cortisone-induced regression of lymphoid tumors in man. Cancer. 1949;2:943–5.PubMed
CrossRef 3. Piller G. The history of leukemia: a personal perspective. Blood Cells. 1993;19:521.PubMed 4. Velpeau A. Sur la resorption du puseat sur l’altération du sang dans les maladies clinique…
Time of observation Number of patients Incidence crude Incidence (WSP)a SEER [28] 1998–2000 – – 1.8b 2003–2007 4,653 – 1.7b France [35] 1985–2006 906 – 0.8 Swedish Cancer…
Acute haemorrhage Malignant disease (e.g. carcinoma, Hodgkin and non-Hodgkin lymphoma) Chronic inflammatory disorders (e.g. rheumatoid arthritis, ulcerative colitis) Acute inflammation Post-operation Splenectomy and hyposplenism Marrow recovery from drug suppression, or…
Working groups: NCIWG/IWCLL [2] Parameter Diagnosis Lymphocytes (× 109/L) >5; ≥1 B-cell marker (CD19, CD20, CD23) + CD5 Atypical cells (%) (e.g. prolymphocytes) <55 Duration of lymphocytosis At least…
Ultrasound CT MRI Advantages Low cost Low cost No radiation Availability Availability High contrast resolution Useful for screening and surveillance Quick Liver-specific agents High spatial resolution Functional MRI Highest…
Fig. 1 IL-6/STAT3 signaling pathway. Shown is a schematic figure of the IL-6/JAK/STAT signaling pathway. Binding of IL-6 to its cognate receptor results in phosphorylation of JAK1/2 with subsequent autophosphorylation of…
Tumor classification Definition Stage Criteria T0, N0, M0 Not found Stage I T1 T1 One nodule <2.0 cm Stage II T2 T2 One nodule 2.0–5.0 cm; 2 or 3 nodules, all <3.0 cm Stage III T3 T3…
Without underlying liver disease With underlying liver disease p value Number 82 124 − Liver disease, n (%) HBV (HBsAg+) HCV (anti-HCV Ab+) NASH Alcoholic liver disease Other −…
Fig. 1 Algorithm for management of transplantable hepatocellular carcinoma at Henri Mondor Hospital, Creteil, France [3] For patients with a solitary HCC<5 cm, no evidence of extrahepatic tumor burden, compensated liver disease,…